These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
646 related articles for article (PubMed ID: 10691142)
1. Nuclear DNA content, an adjunct to p53 and Ki-67 as a marker of resistance to radiation therapy in oral cavity and pharyngeal squamous cell carcinoma. Raybaud H; Fortin A; Bairati I; Morency R; Monteil RA; Têtu B Int J Oral Maxillofac Surg; 2000 Feb; 29(1):36-41. PubMed ID: 10691142 [TBL] [Abstract][Full Text] [Related]
2. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings]. Esser D; Anke S; Roessner A; Freigang B Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912 [TBL] [Abstract][Full Text] [Related]
3. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity]. Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715 [TBL] [Abstract][Full Text] [Related]
4. p53 protein overexpression is associated with increased cell proliferation in patients with locally recurrent prostate carcinoma after radiation therapy. Cheng L; Sebo TJ; Cheville JC; Pisansky TM; Slezak J; Bergstralh EJ; Pacelli A; Neumann RM; Zincke H; Bostwick DG Cancer; 1999 Mar; 85(6):1293-9. PubMed ID: 10189134 [TBL] [Abstract][Full Text] [Related]
5. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080 [TBL] [Abstract][Full Text] [Related]
6. DNA ploidy, P53 expression, and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi. Itakura Y; Sasano F; Date F; Kato K; Sekine H; Mori S; Nagura H Anticancer Res; 1996; 16(1):201-8. PubMed ID: 8615609 [TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma. Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127 [TBL] [Abstract][Full Text] [Related]
8. [Tumor biologic prognostic parameters in T1N0M0 squamous cell carcinoma of the oral cavity]. Welkoborsky HJ; Gluckman JL; Jacob R; Bernauer H; Mann W Laryngorhinootologie; 1999 Mar; 78(3):131-8. PubMed ID: 10226980 [TBL] [Abstract][Full Text] [Related]
9. Ki-67 expression predicts radiosensitivity in oral squamous cell carcinoma. Freudlsperger C; Freier K; Hoffmann J; Engel M Int J Oral Maxillofac Surg; 2012 Aug; 41(8):965-9. PubMed ID: 22591716 [TBL] [Abstract][Full Text] [Related]
10. p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: possible biopotential markers in human prostatic cancer. Papadopoulos I; Rudolph P; Wirth B; Weichert-Jacobsen K Urology; 1996 Aug; 48(2):261-8. PubMed ID: 8753738 [TBL] [Abstract][Full Text] [Related]
11. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study. Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093 [TBL] [Abstract][Full Text] [Related]
12. Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as prognostic factors of recurrence in T1 and T2 laryngeal carcinoma. Sittel C; Eckel HE; Damm M; von Pritzbuer E; Kvasnicka HM Laryngoscope; 2000 Jun; 110(6):1012-7. PubMed ID: 10852523 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study. Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE; J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979 [TBL] [Abstract][Full Text] [Related]
14. Predictive value of proliferation-related markers, p53, and DNA ploidy for survival in patients with soft tissue spindle-cell sarcomas. Golouh R; Bracko M; Novak J Mod Pathol; 1996 Sep; 9(9):919-24. PubMed ID: 8878024 [TBL] [Abstract][Full Text] [Related]
15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of clinical factors and p53 expression in patients with glottic carcinoma treated with radiation therapy. Kokoska MS; Piccirillo JF; el-Mofty SK; Emami B; Haughey BH; Schoinick SB Cancer; 1996 Oct; 78(8):1693-700. PubMed ID: 8859182 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis. Mise K; Tashiro S; Yogita S; Wada D; Harada M; Fukuda Y; Miyake H; Isikawa M; Izumi K; Sano N Clin Cancer Res; 1998 Jun; 4(6):1475-82. PubMed ID: 9626465 [TBL] [Abstract][Full Text] [Related]
19. Radiation induced early nuclear changes in cytologic brush specimens from the upper aerodigestive tract. Ambrosch P; Ruschenburg I In Vivo; 2000; 14(6):757-60. PubMed ID: 11204495 [TBL] [Abstract][Full Text] [Related]
20. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Lavertu P; Adelstein DJ; Myles J; Secic M Laryngoscope; 2001 Nov; 111(11 Pt 1):1878-92. PubMed ID: 11801963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]